Physician profile
Nga Vu
NPI 1922268135
$929.55
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $597 · 2020: $13.76 · 2021: $12.12 · 2024: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $306.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $260.55 | 2019 | |
| Vertos Medical, INC. | $142.86 | 2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $134.16 | 2019-2021 | |
| Medtronic, INC. | $120.00 | 2024 | Intellis Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $83.07 | 2019 | |
| Eli Lilly and Company | $43.51 | 2024 | |
| Kaleo, INC. | $40.11 | 2019 | |
| Horizon Therapeutics Plc | $24.95 | 2019 | |
| Sentynl Therapeutics, INC. | $23.35 | 2019 | |
| Electronic Waveform Lab, INC. | $18.37 | 2019 | |
| Amgen INC. | $15.35 | 2019 | |
| Avanir Pharmaceuticals, INC. | $11.73 | 2019 | |
| Boston Scientific Corporation | $11.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nga Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.